$ENTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENANTA PHARMACEUTICALS INC. Get notifications about new insider transactions in ENANTA PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.92 | 12,300 | 478,700 | 547,038 | 559.3 K to 547 K (-2.20 %) |
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 40.70 | 200 | 8,139 | 189,078 | 189.3 K to 189.1 K (-0.11 %) |
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 40.22 | 1,600 | 64,349 | 189,278 | 190.9 K to 189.3 K (-0.84 %) |
Apr 02 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 38.92 | 8,200 | 319,134 | 190,878 | 199.1 K to 190.9 K (-4.12 %) |
Mar 25 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 40.36 | 3,116 | 125,750 | 199,078 | 202.2 K to 199.1 K (-1.54 %) |
Mar 25 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 39.66 | 2,521 | 99,978 | 202,194 | 204.7 K to 202.2 K (-1.23 %) |
Mar 25 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Sell | S | 38.42 | 4,363 | 167,624 | 204,715 | 209.1 K to 204.7 K (-2.09 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.73 | 4,350 | 3,187 | 0 | |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.73 | 73,102 | 53,562 | 0 | |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.73 | 14,680 | 10,756 | 0 | |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.73 | 4,350 | 3,187 | 176,397 | 172 K to 176.4 K (+2.53 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.73 | 73,102 | 53,562 | 172,047 | 98.9 K to 172 K (+73.88 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.73 | 14,680 | 10,756 | 98,945 | 84.3 K to 98.9 K (+17.42 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 39.32 | 2,685 | 105,576 | 559,338 | 562 K to 559.3 K (-0.48 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.77 | 3,615 | 140,136 | 562,023 | 565.6 K to 562 K (-0.64 %) |
Mar 12 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 37.61 | 3,700 | 139,156 | 565,638 | 569.3 K to 565.6 K (-0.65 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.82 | 274,880 | 10,669,605 | 1,178,534 | 1.5 M to 1.2 M (-18.91 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.82 | 88,877 | 3,449,805 | 381,052 | 469.9 K to 381.1 K (-18.91 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.82 | 66,506 | 2,581,464 | 285,129 | 351.6 K to 285.1 K (-18.91 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.83 | 5,795 | 225,041 | 1,453,414 | 1.5 M to 1.5 M (-0.40 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.83 | 1,874 | 72,774 | 469,929 | 471.8 K to 469.9 K (-0.40 %) |
Mar 05 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.83 | 1,402 | 54,445 | 351,635 | 353 K to 351.6 K (-0.40 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 34,237 | 1,367,111 | 1,459,209 | 1.5 M to 1.5 M (-2.29 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 11,069 | 441,994 | 471,803 | 482.9 K to 471.8 K (-2.29 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.93 | 8,283 | 330,747 | 353,037 | 361.3 K to 353 K (-2.29 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 112,826 | 4,391,064 | 1,493,446 | 1.6 M to 1.5 M (-7.02 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 36,478 | 1,419,684 | 482,872 | 519.4 K to 482.9 K (-7.02 %) |
Feb 27 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 38.92 | 27,297 | 1,062,369 | 361,320 | 388.6 K to 361.3 K (-7.02 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 33,602 | 1,327,591 | 1,572,670 | 1.6 M to 1.6 M (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 10,865 | 429,269 | 508,485 | 519.4 K to 508.5 K (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 39.51 | 8,130 | 321,211 | 380,487 | 388.6 K to 380.5 K (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 5,034 | 201,360 | 1,606,272 | 1.6 M to 1.6 M (-0.31 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 1,628 | 65,120 | 519,350 | 521 K to 519.4 K (-0.31 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.00 | 1,218 | 48,720 | 388,617 | 389.8 K to 388.6 K (-0.31 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 33,602 | 1,327,591 | 1,572,670 | 1.6 M to 1.6 M (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 10,865 | 429,269 | 508,485 | 519.4 K to 508.5 K (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 39.51 | 8,130 | 321,211 | 380,487 | 388.6 K to 380.5 K (-2.09 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 5,034 | 201,360 | 1,606,272 | 1.6 M to 1.6 M (-0.31 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 1,628 | 65,120 | 519,350 | 521 K to 519.4 K (-0.31 %) |
Feb 25 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.00 | 1,218 | 48,720 | 388,617 | 389.8 K to 388.6 K (-0.31 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 6,388 | 256,704 | 1,611,306 | 1.6 M to 1.6 M (-0.39 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 2,066 | 83,023 | 520,978 | 523 K to 521 K (-0.39 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Sell | S | 40.19 | 1,546 | 62,126 | 389,835 | 391.4 K to 389.8 K (-0.40 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 6,388 | 257,555 | 1,611,306 | 1.6 M to 1.6 M (-0.39 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 5,066 | 204,254 | 520,978 | 526 K to 521 K (-0.96 %) |
Feb 20 2014 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Sell | S | 40.32 | 1,546 | 62,332 | 389,935 | 391.5 K to 389.9 K (-0.39 %) |
Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 38.52 | 2,385 | 91,862 | 569,338 | 571.7 K to 569.3 K (-0.42 %) |
Feb 14 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 37.81 | 3,415 | 129,113 | 571,723 | 575.1 K to 571.7 K (-0.59 %) |
Feb 11 2014 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 36.61 | 9,280 | 339,741 | 9,280 | |
Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | Vance Terry | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
Feb 10 2014 | ENTA | ENANTA PHARMACEUTI ... | Buckley Stephen Jr. | Director | Option Exercise | A | 35.00 | 4,640 | 162,400 | 4,640 | |
Feb 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Option Exercise | A | 32.43 | 70,000 | 2,270,100 | 70,000 | |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 0.73 | 7,250 | 5,312 | 0 | |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | M | 0.73 | 121,837 | 89,270 | 0 | |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 0.73 | 7,250 | 5,312 | 209,078 | 201.8 K to 209.1 K (+3.59 %) |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Buy | M | 0.73 | 121,837 | 89,270 | 201,828 | 80 K to 201.8 K (+152.31 %) |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 7,445 | 5,455 | 7,055 | |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | M | 0.73 | 243,674 | 178,540 | 0 | |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 7,445 | 5,455 | 575,138 | 567.7 K to 575.1 K (+1.31 %) |
Jan 13 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Buy | M | 0.73 | 243,674 | 178,540 | 567,693 | 324 K to 567.7 K (+75.20 %) |
Jan 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 28.43 | 1,170 | 33,258 | 324,019 | 325.2 K to 324 K (-0.36 %) |
Jan 03 2014 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Sell | S | 27.96 | 4,630 | 129,441 | 325,189 | 329.8 K to 325.2 K (-1.40 %) |
Dec 13 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Sell | S | 37.92 | 2,100 | 79,622 | 17,287 | 19.4 K to 17.3 K (-10.83 %) |
Dec 13 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Sell | S | 37.20 | 7,100 | 264,111 | 19,387 | 26.5 K to 19.4 K (-26.81 %) |
Dec 13 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Sell | S | 36.38 | 5,800 | 210,990 | 26,487 | 32.3 K to 26.5 K (-17.96 %) |
Dec 09 2013 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 29.66 | 12,500 | 370,750 | 12,500 | |
Dec 09 2013 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 29.66 | 12,500 | 370,750 | 12,500 | |
Dec 09 2013 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 29.66 | 25,000 | 741,500 | 25,000 | |
Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | Goldberg Marc E. | Director | Sell | S | 27.93 | 6,861 | 191,614 | 547,606 | 554.5 K to 547.6 K (-1.24 %) |
Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | A | 27.58 | 35,000 | 965,300 | 35,000 | |
Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Option Exercise | A | 27.58 | 70,000 | 1,930,600 | 70,000 | |
Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Chief Scientific Of ... | Option Exercise | A | 27.58 | 35,000 | 965,300 | 35,000 | |
Dec 06 2013 | ENTA | ENANTA PHARMACEUTI ... | CARTER BRUCE L A | Director | Option Exercise | A | 23.40 | 9,280 | 217,152 | 9,280 | |
Nov 27 2013 | ENTA | ENANTA PHARMACEUTI ... | Goldberg Marc E. | Director | Sell | S | 26.08 | 15,554 | 405,608 | 554,467 | 570 K to 554.5 K (-2.73 %) |
Nov 27 2013 | ENTA | ENANTA PHARMACEUTI ... | Goldberg Marc E. | Director | Sell | S | 25.61 | 34,446 | 882,124 | 570,021 | 604.5 K to 570 K (-5.70 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 19.83 | 25,553 | 506,683 | 1,425,708 | 1.5 M to 1.4 M (-1.76 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 19.83 | 3,640 | 72,176 | 203,113 | 206.8 K to 203.1 K (-1.76 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 19.83 | 2,607 | 51,693 | 145,442 | 148 K to 145.4 K (-1.76 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 19.83 | 303 | 6,008 | 16,904 | 17.2 K to 16.9 K (-1.76 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.05 | 158 | 3,326 | 1,451,261 | 1.5 M to 1.5 M (-0.01 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.05 | 22 | 463 | 206,753 | 206.8 K to 206.8 K (-0.01 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.05 | 16 | 337 | 148,049 | 148.1 K to 148 K (-0.01 %) |
Oct 16 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.05 | 2 | 42 | 17,207 | 17.2 K to 17.2 K (-0.01 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.06 | 8,920 | 187,822 | 1,451,419 | 1.5 M to 1.5 M (-0.61 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.06 | 1,271 | 26,763 | 206,775 | 208 K to 206.8 K (-0.61 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.06 | 910 | 19,161 | 148,065 | 149 K to 148.1 K (-0.61 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 21.06 | 106 | 2,232 | 17,209 | 17.3 K to 17.2 K (-0.61 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.00 | 19,899 | 437,778 | 1,460,339 | 1.5 M to 1.5 M (-1.34 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.00 | 2,835 | 62,370 | 208,046 | 210.9 K to 208 K (-1.34 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.00 | 2,030 | 44,660 | 148,975 | 151 K to 149 K (-1.34 %) |
Oct 11 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.00 | 236 | 5,192 | 17,315 | 17.6 K to 17.3 K (-1.34 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.85 | 3,263 | 74,546 | 1,480,238 | 1.5 M to 1.5 M (-0.22 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.66 | 6,527 | 154,416 | 1,483,501 | 1.5 M to 1.5 M (-0.44 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.85 | 465 | 10,623 | 210,881 | 211.3 K to 210.9 K (-0.22 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.66 | 930 | 22,002 | 211,346 | 212.3 K to 211.3 K (-0.44 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.85 | 333 | 7,608 | 151,005 | 151.3 K to 151 K (-0.22 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.66 | 666 | 15,756 | 151,338 | 152 K to 151.3 K (-0.44 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 22.85 | 39 | 891 | 17,551 | 17.6 K to 17.6 K (-0.22 %) |
Oct 04 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.66 | 77 | 1,822 | 17,590 | 17.7 K to 17.6 K (-0.44 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.54 | 147,810 | 3,479,536 | 1,490,028 | 1.6 M to 1.5 M (-9.02 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.13 | 11,383 | 263,287 | 1,637,838 | 1.6 M to 1.6 M (-0.69 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.54 | 21,058 | 495,718 | 212,276 | 233.3 K to 212.3 K (-9.02 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.13 | 1,622 | 37,517 | 233,334 | 235 K to 233.3 K (-0.69 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.54 | 15,079 | 354,969 | 152,004 | 167.1 K to 152 K (-9.02 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.13 | 1,160 | 26,831 | 167,083 | 168.2 K to 167.1 K (-0.69 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.54 | 1,753 | 41,267 | 17,667 | 19.4 K to 17.7 K (-9.03 %) |
Oct 02 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Sell | S | 23.13 | 135 | 3,123 | 19,420 | 19.6 K to 19.4 K (-0.69 %) |
Jul 11 2013 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Option Exercise | M | 0.73 | 84,265 | 61,741 | 0 | |
Jul 11 2013 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Buy | M | 0.73 | 84,265 | 61,741 | 84,265 | 0 to 84.3 K |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,827,508 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,028,374 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,000,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Buy | C | 0.00 | 424,014 | 0 | 2,071,975 | 1.6 M to 2.1 M (+25.73 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Buy | C | 0.00 | 924,523 | 0 | 1,647,961 | 723.4 K to 1.6 M (+127.80 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Buy | C | 0.00 | 621,262 | 0 | 723,438 | 102.2 K to 723.4 K (+608.03 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SAINTS CAPITAL GRANITE, L.P. | 10% Owner | Buy | P | 14.00 | 66,474 | 930,636 | 102,176 | 35.7 K to 102.2 K (+186.19 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 2,061,246 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 3,296,888 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 563,503 | 0 | 3,296,888 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 1,130,000 | 0 | 500,000 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Option Exercise | C | 0.00 | 1,017,442 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | P | 14.00 | 132,949 | 1,861,286 | 2,532,119 | 2.4 M to 2.5 M (+5.54 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 478,247 | 0 | 2,399,170 | 1.9 M to 2.4 M (+24.90 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 1,006,498 | 0 | 1,920,923 | 914.4 K to 1.9 M (+110.07 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 172,030 | 0 | 914,425 | 742.4 K to 914.4 K (+23.17 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 155,316 | 0 | 742,395 | 587.1 K to 742.4 K (+26.46 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 351,014 | 0 | 587,079 | 236.1 K to 587.1 K (+148.69 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | SCHUHSLER HELMUT | Director | Buy | C | 0.00 | 236,065 | 0 | 236,065 | 0 to 236.1 K |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 2,061,246 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 3,296,888 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 563,503 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 1,130,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Option Exercise | C | 0.00 | 1,017,442 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | P | 14.00 | 132,949 | 1,861,286 | 1,617,694 | 1.5 M to 1.6 M (+8.95 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 478,247 | 0 | 1,484,745 | 1 M to 1.5 M (+47.52 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 1,006,498 | 0 | 1,006,498 | 0 to 1 M |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 172,030 | 0 | 523,044 | 351 K to 523 K (+49.01 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 155,316 | 0 | 391,381 | 236.1 K to 391.4 K (+65.79 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 351,014 | 0 | 351,014 | 0 to 351 K |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | TVM V LIFE SCIENCE VENTURES GM ... | 10% Owner | Buy | C | 0.00 | 236,065 | 0 | 236,065 | 0 to 236.1 K |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | C | 0.00 | 48,337 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | C | 0.00 | 320 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | C | 0.00 | 2,906 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | C | 0.00 | 10,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Option Exercise | C | 0.00 | 10,000 | 0 | 0 | |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Buy | C | 0.00 | 11,215 | 0 | 32,287 | 21.1 K to 32.3 K (+53.22 %) |
Mar 28 2013 | ENTA | ENANTA PHARMACEUTI ... | AFTING ERNST-GUENTER | Director | Buy | C | 0.00 | 97 | 0 | 21,072 | 21 K to 21.1 K (+0.46 %) |